Eli Lilly and Company sustainability score: 39/100
Eli Lilly is a $45B US pharmaceutical company headquartered in Indianapolis, founded in 1876. A major player in therapeutics, vaccines, and animal health, the company manufactures across global sites and sources from complex supply chains.
More about Eli Lilly and Company
It operates in a sector facing rising scrutiny over environmental impact and access to medicines.
Founded 1876Head office Indianapolis, United StatesStaff ~43,000Revenue $45.0B (FY2024)Website ↗
Eli Lilly has renewable energy momentum but weak climate fundamentals. Scope 1 emissions rose 5.5% in 2024 despite carbon neutrality claims. No SBTi targets, no Scope 3 reduction plans, and active trade association opposition to climate policy undermine credibility. Greenwashing risk is material.
Eli Lilly and Company scores 39/100 (Below expectations) on SINK's independent climate assessment, scored from public data only. Scores are free. Companies can never pay for anything about their own score. Last verified May 2026.
That places Eli Lilly and Company joint 432nd of 934 companies scored, and joint 13th of 22 in Healthcare / Pharmaceuticals.
What is Eli Lilly and Company doing well, and where does it fall short?
Strongest on Carbon Footprint: Operations and Carbon Footprint: Supply Chain (7/10, 6/10). Weakest on Controversies & Red Flags and Targets & Commitments (1/10, 3/10).
Where Eli Lilly and Company lost points
For each question that lost points, the evidence our public rubric looks for that we didn't find.
- Emissions from its own operations7/10Its own emissions aren't independently verified or tracked over several years.
- Emissions from its supply chain6/10No full value-chain map or supplier engagement programme.
- Whether its emissions are falling4/10No evidence of a year-on-year fall in its total emissions.
- How clean its energy is6/10Less than 90% of its energy shown to be renewable.
- Its effect on nature4/10Its effect on nature isn't measured or independently verified.
- How it uses materials and handles waste6/10No verified figures for reuse and recycling across the business.
- Its effect on water5/10No measured water footprint with reduction targets.
- Its climate targets3/10No specific targets with dates.
- How openly it reports6/10No annual impact report, or no pay linked to climate targets.
- Its record on controversies1/10Points deducted for controversies or its business model. The finding is under question 10.
A score changes when the evidence does. We use new published evidence at the next rescore. Anyone can send us new evidence, free. How to send it.
How is Eli Lilly and Company's SINK score calculated?
Same ten questions for every company. No private weighting.
SINK = (0.3 × Base + 0.7 × Performance) × ScaleWhat evidence is Eli Lilly and Company's score based on?
15 sources used in this assessment. All publicly available. Each row shows which of the ten questions it informed.
47% of them were published by Eli Lilly and Company itself; the rest come from independent sources.
Scored on 4 April 2026 under an earlier version of our method. We're re-checking it under the current method.
8 of 15 sources are independent of the company.
If you believe a source has been misread or a newer version exists, submit a challenge.
Is this your company? Claim this profile (free)
Use this score in tenders
Send the link, or the one-page score sheet. It links back to this page and every source. Free.
Open the score sheet →Send new evidence, free
Scored low because little is published? Publish what you do and send us the link, free. If it holds up, your score changes, and the change is logged on your page.
How to send evidence →Put your score on your website, free
It shows the current score and links to this page, so it changes when the score does.
Track this score
Bidding for a public contract? Check if you need a Carbon Reduction Plan, free →
Want your own page like this?
Free, independent, every source shown. Send it to any buyer who asks about your sustainability.
How does Eli Lilly and Company compare with other healthcare / pharmaceuticals companies?
Where Eli Lilly and Company sits among healthcare / pharmaceuticals peers.
Among the 22 major healthcare / pharmaceuticals brands we've scored, Eli Lilly and Company is tied =13th of 22, with 3 others.
Who scores higher in Healthcare / Pharmaceuticals?
The 3 companies in the sector scoring nearest above Eli Lilly and Company.
Pharmacy2U's footprint was 417,388 tCO2e in its year to March 2025, almost all of it (407,000 t) the medicines it buys; its earlier, much lower totals left most of its supply chain out.
See the breakdown →Novo Nordisk's total emissions rose for a third year, up 19% in 2025 to 2.69 MtCO2e, and the company says it made no reductions that year.
See the breakdown →Which companies moved this week, and why.
One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.
We'll send one email to confirm. No spam. Unsubscribe in one click.
Checking a company?
Search free →Asked to prove you're sustainable?
Get your business scored, free →Been scored?
Find your page and claim it, free →Scores are free. Companies can never pay for anything about their own score.